Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SON | Ann:Company Removed from Official List - Failure to pay Annual Listing Fee - 2017/2018 - Delisted... | 18/09/17 | 0 | 944 | |||
|
|||||||
SON | Ann:Continued Suspension - Company have complied with lodging financials. Company to remain under... | 18/09/17 | 0 | 908 | |||
|
|||||||
SON | Ann:2017 Annual Report (Price Sensitive) | 18/09/17 | 0 | 933 | |||
|
|||||||
SON | Ann:31 December 2015 Review (Price Sensitive) | 18/09/17 | 0 | 955 | |||
|
|||||||
SON | Ann:December 2018 review (Price Sensitive) | 18/09/17 | 0 | 936 | |||
|
|||||||
SON | Ann:Continued Suspension - Failure to release Preliminary Final Report for 30 June 2017 (Price... | 14/09/17 | 0 | 912 | |||
|
|||||||
SON | Ann:AGM 2016 | 14/09/17 | 0 | 1.5K | |||
|
|||||||
SON | Ann:2016 AGM Results | 14/09/17 | 0 | 767 | |||
|
See All Discussions